Emerald Therapeutics

Emerald Therapeutics

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California, and was founded in 2013 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab.

The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Funding

Series A

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong.

Series B

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin.

Series C

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund.

Timeline

June 19, 2015

Series C funding round

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund.

March 1, 2014

Series B funding round

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin.

December 27, 2010

Series A funding round

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong.

2010

Founding of Emerald therapeutics

Emerald Therapeutics was founded in 2010 by Brian Frezza and DJ Kleinbaum

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Emerald Cloud Lab Venture Funding Round December 2010
7,800,000
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Ashby Monk

Investor

Brian Frezza

Co-Founder

Brian Singerman

Board Member

DJ Kleinbaum

Co-Founder

Eric Shyr

Employee

Gaetano Moreloo

Chief Scientific Officer and Board Member

James Hong

Investor

James McKernan

Employee

Jimmy Demesa

CEO

John Tomcat Sanderson

Employee

Joi Ito

Investor

MJD MJD

Investor

Shan Sinha

Investor

Further reading

Title
Author
Link
Type
Date

Founders Fund Backs a Robotic Lab that Puts Science in the Cloud

James Temple

News Article

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.